Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,097 | 82 | 99.3% |
| Education | $7.86 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $463.33 | 35 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $167.65 | 13 | $0 (2020) |
| PFIZER INC. | $142.05 | 13 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $124.54 | 8 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $38.42 | 3 | $0 (2018) |
| GENZYME CORPORATION | $29.55 | 1 | $0 (2023) |
| Gilead Sciences Inc | $28.79 | 2 | $0 (2017) |
| Daiichi Sankyo Inc. | $19.54 | 1 | $0 (2019) |
| UCB, Inc. | $17.54 | 1 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $15.98 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12.50 | 1 | Micro-tech Endoscopy USA, Inc. ($12.50) |
| 2023 | $62.15 | 3 | ABBVIE INC. ($32.60) |
| 2021 | $57.21 | 4 | AbbVie Inc. ($57.21) |
| 2020 | $174.98 | 12 | AbbVie Inc. ($59.98) |
| 2019 | $579.12 | 47 | AbbVie, Inc. ($203.33) |
| 2018 | $146.84 | 11 | AbbVie, Inc. ($84.05) |
| 2017 | $72.49 | 5 | Gilead Sciences Inc ($28.79) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Micro-tech Endoscopy USA, Inc. | Cold Snares (Device) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: GI Endoscopy | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Immunology | ||||||
| 05/03/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/04/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 02/19/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/02/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/25/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Immunology | ||||||
| 02/17/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/10/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: IMMUNOLOGY | ||||||
| 02/04/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/28/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/21/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $11.17 | General |
| Category: GI | ||||||
| 01/14/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: IMMUNOLOGY | ||||||
| 01/08/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/19/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $1.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Anemia | ||||||
| 12/16/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Lower GI | ||||||
| 12/16/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 694 | 732 | $513,877 | $71,502 |
| 2022 | 14 | 611 | 689 | $472,773 | $66,069 |
| 2021 | 16 | 747 | 804 | $507,551 | $77,071 |
| 2020 | 16 | 773 | 2,945 | $479,119 | $63,723 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 126 | 127 | $159,986 | $14,230 | 8.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 49 | 50 | $71,206 | $9,120 | 12.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 74 | $15,984 | $7,072 | 44.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 91 | $84,217 | $5,071 | 6.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 45 | 50 | $25,240 | $4,988 | 19.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 24 | 24 | $25,624 | $4,117 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 64 | $6,380 | $3,857 | 60.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $6,833 | $3,439 | 50.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $35,788 | $3,364 | 9.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $24,603 | $3,125 | 12.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $18,093 | $2,921 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 34 | $4,976 | $2,880 | 57.9% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $11,366 | $2,083 | 18.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $4,486 | $1,818 | 40.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 19 | $1,997 | $1,138 | 57.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $13,832 | $857.88 | 6.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $2,084 | $780.69 | 37.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 18 | $1,182 | $640.05 | 54.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 99 | 100 | $122,564 | $9,716 | 7.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 50 | 52 | $72,202 | $9,221 | 12.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 64 | 70 | $14,646 | $7,015 | 47.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 79 | 86 | $77,303 | $5,589 | 7.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 56 | 60 | $47,306 | $4,659 | 9.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 23 | 23 | $23,878 | $3,910 | 16.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 29 | 36 | $17,556 | $3,779 | 21.5% |
About Dr. Shane Hendon, D.O
Dr. Shane Hendon, D.O is a Internal Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992757975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shane Hendon, D.O has received a total of $1,105 in payments from pharmaceutical and medical device companies, with $12.50 received in 2024. These payments were reported across 83 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,097).
As a Medicare-enrolled provider, Hendon has provided services to 2,825 Medicare beneficiaries, totaling 5,170 services with total Medicare billing of $278,366. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Paducah, KY
- Active Since 05/17/2006
- Last Updated 04/21/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1992757975
Products in Payments
- Humira (Biological) $184.56
- XELJANZ (Drug) $142.05
- HUMIRA (Biological) $117.19
- Mavyret (Drug) $98.51
- TRULANCE (Drug) $66.07
- XIFAXAN (Drug) $58.47
- Entyvio (Biological) $57.72
- Trulance (Drug) $38.42
- Motegrity (Drug) $34.35
- VIBERZI (Drug) $32.60
- ENTYVIO (Biological) $31.09
- DUPIXENT (Biological) $29.55
- Creon (Drug) $20.35
- MOTEGRITY (Drug) $19.67
- INJECTAFER (Drug) $19.54
- Cimzia (Drug) $17.54
- OCALIVA (Drug) $15.98
- DIFICID (Drug) $12.67
- STELARA (Biological) $12.53
- Cold Snares (Device) $12.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paducah
Dr. Martin Rains, M.d, M.D
Internal Medicine — Payments: $48,397
Dr. Wederson Claudino, Md, MD
Internal Medicine — Payments: $29,178
Jacob Elrod, Md, MD
Internal Medicine — Payments: $24,847
Michael Faulkner, M.d, M.D
Internal Medicine — Payments: $16,943
Ryan Frazine, M.d, M.D
Internal Medicine — Payments: $10,062
Dr. Van Meeks, M.d, M.D
Internal Medicine — Payments: $7,786